OA activity and ALDH1 status should be further investigated in detail as a potential prognostic and therapeutic target to prevent the transition from DCIS to invasive breast cancer in translating DCIS research into clinical practice. This evidence concerns the gene ALDH1A1 and invasive breast carcinoma.